Revvity, Inc.
corporate_fare Company Profile
Revvity, Inc. (NYSE:RVTY) is a publicly traded company in the Industrial Applications And Services sector. Wiseek has independently scored 17 items for RVTY at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-03, rated 8/10. Across its 17 most recent items scored 7 or higher, the top rating is 8/10, with 9 rated 8 or above. Recent SEC coverage for RVTY spans 8-K, 10-Q, DEF 14A, PRE 14A.
Recent high-impact activity:
- Revvity Beats Q3, Raises FY2026 Guidance to $5.40-$5.45 Pro Forma Adjusted EPS
- Revvity Beats on Q3 Growth, Guides FY26 Adjusted EPS to $5.40-$5.45
- Revvity to Acquire Human Cell Design, Bolstering Metabolic Disease Drug Discovery
- Revvity Q2 2026: 1% Revenue Growth, $46M Restructuring, and China Immunodiagnostics Divestiture
- Revvity Raises 2026 Outlook on Diagnostics Surge, Sells China Unit
Financial Snapshot
Short Interest & Short Volume
3.56 days to coverFINRA reported short interest of 6,391,660 shares in RVTY as of the October 15, 2026 settlement, a 1.4% increase from the prior period — about 3.6 days to cover at its recent average daily volume. On November 4, 2026, 42.6% of RVTY volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.